- Nasdaq-100 After-Hours Indicator Down 15.23 at 2,116.25
- AVNR, -2%
- declined in after-hours trade after the company announced plans for a stock offering. AVNR dropped to an early after-hours low of 4.40 before popping to a negative range of 4.54 to 4.45 through the first-half of night trade. The stock weakened into the second-half, sliding to a range of 4.50 to 4.40. Evening indications would suggest AVNR records a potential pre-market open Wednesday in the 4.50 to 4.40 range. Shorts may want to eye the 4.54 to 4.50 range as a potential downside entry point as this area held as a ceiling level through much of tonight's first-half and through the mid-session.
- CMA, +3.4%
- BOBE, -2.1%
GSK: 38.55 to 39.95
CMA: 36.74 to 38.10
HOTT: 5.43 to 5.52
DOWNSIDE MOVERS:
AVNR: 4.62 to 4.40
CBOU: 10.65 to 10.43
BA: 63.61 to 62.63
BOBE: 29.96 to 28.65
- SINA: -1.7%; beats with Q3 results, guides for Q4 revenue below Street.
- BOBE: -2.7%; Q2 results below year-ago levels.
- HOTT: steady; Q3 sales just ahead of expectations, discloses cost reduction plan.
- Shares of Human Genome Sciences Inc. (HGSI:$25.88,00$2.28,009.66%) and GlaxoSmithKline Plc (GSK:...) each climbed Tuesday evening after a regulatory panel recommended for approval the companies' treatment for lupus.
